Article Versions Notes

Shirouchi B, Mitsuta S, Higuchi M, Okumura M, Tanaka K. Dietary Nicotinamide Mononucleotide, a Key NAD⁺ Intermediate, Alleviates Body Fat Mass and Hypertriglyceridemia by Enhancing Energy Expenditure with Promotion of Fat Oxidation and Hepatic Lipolysis and Suppressing Hepatic Lipogenesis in db/db Mice. Metabolites. 2025; 15(5):333. https://doi.org/10.3390/metabo15050333

Shirouchi, Bungo, Sarasa Mitsuta, Mina Higuchi, Mai Okumura, and Kazunari Tanaka. 2025. "Dietary Nicotinamide Mononucleotide, a Key NAD⁺ Intermediate, Alleviates Body Fat Mass and Hypertriglyceridemia by Enhancing Energy Expenditure with Promotion of Fat Oxidation and Hepatic Lipolysis and Suppressing Hepatic Lipogenesis in db/db Mice" Metabolites 15, no. 5: 333. https://doi.org/10.3390/metabo15050333

Shirouchi, B., Mitsuta, S., Higuchi, M., Okumura, M., & Tanaka, K. (2025). Dietary Nicotinamide Mononucleotide, a Key NAD⁺ Intermediate, Alleviates Body Fat Mass and Hypertriglyceridemia by Enhancing Energy Expenditure with Promotion of Fat Oxidation and Hepatic Lipolysis and Suppressing Hepatic Lipogenesis in db/db Mice. Metabolites, 15(5), 333. https://doi.org/10.3390/metabo15050333